Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Endometriosis Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Endometriosis Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Endometriosis Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Pfizer
Repros Therapeutics
Takeda Pharmaceutical Company Limited
ObsEva
Kissei Pharmaceutical
Roivant Sciences GmbH
Neurocrine Biosciences
Astellas Pharma
Debiopharm Group
AstraZeneca
ValiRx
AbbVie
Evotec AG
By Type:
Hormonal Therapy
Add-back Medication
Progestogens
Chinese Herbs
By End-User:
Hospitals
Clinics
Research Institutes
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Endometriosis Drugs Market
-
1.3 Market Segment by Type
1.3.1 Japan Endometriosis Drugs Market Size and Growth Rate of Hormonal Therapy from 2014 to 2026
1.3.2 Japan Endometriosis Drugs Market Size and Growth Rate of Add-back Medication from 2014 to 2026
1.3.3 Japan Endometriosis Drugs Market Size and Growth Rate of Progestogens from 2014 to 2026
1.3.4 Japan Endometriosis Drugs Market Size and Growth Rate of Chinese Herbs from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Endometriosis Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026
1.4.2 Japan Endometriosis Drugs Market Size and Growth Rate of Clinics from 2014 to 2026
1.4.3 Japan Endometriosis Drugs Market Size and Growth Rate of Research Institutes from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Endometriosis Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Endometriosis Drugs by Major Types
3.4.1 Market Size and Growth Rate of Hormonal Therapy
3.4.2 Market Size and Growth Rate of Add-back Medication
3.4.3 Market Size and Growth Rate of Progestogens
3.4.4 Market Size and Growth Rate of Chinese Herbs
4 Segmentation of Endometriosis Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Endometriosis Drugs by Major End-Users
4.4.1 Market Size and Growth Rate of Endometriosis Drugs in Hospitals
4.4.2 Market Size and Growth Rate of Endometriosis Drugs in Clinics
4.4.3 Market Size and Growth Rate of Endometriosis Drugs in Research Institutes
5 Market Analysis by Regions
-
5.1 Japan Endometriosis Drugs Production Analysis by Regions
-
5.2 Japan Endometriosis Drugs Consumption Analysis by Regions
6 Hokkaido Endometriosis Drugs Landscape Analysis
-
6.1 Hokkaido Endometriosis Drugs Landscape Analysis by Major Types
-
6.2 Hokkaido Endometriosis Drugs Landscape Analysis by Major End-Users
7 Tohoku Endometriosis Drugs Landscape Analysis
-
7.1 Tohoku Endometriosis Drugs Landscape Analysis by Major Types
-
7.2 Tohoku Endometriosis Drugs Landscape Analysis by Major End-Users
8 Kanto Endometriosis Drugs Landscape Analysis
-
8.1 Kanto Endometriosis Drugs Landscape Analysis by Major Types
-
8.2 Kanto Endometriosis Drugs Landscape Analysis by Major End-Users
9 Chubu Endometriosis Drugs Landscape Analysis
-
9.1 Chubu Endometriosis Drugs Landscape Analysis by Major Types
-
9.2 Chubu Endometriosis Drugs Landscape Analysis by Major End-Users
10 Kinki Endometriosis Drugs Landscape Analysis
-
10.1 Kinki Endometriosis Drugs Landscape Analysis by Major Types
-
10.2 Kinki Endometriosis Drugs Landscape Analysis by Major End-Users
11 Chugoku Endometriosis Drugs Landscape Analysis
-
11.1 Chugoku Endometriosis Drugs Landscape Analysis by Major Types
-
11.2 Chugoku Endometriosis Drugs Landscape Analysis by Major End-Users
12 Shikoku Endometriosis Drugs Landscape Analysis
-
12.1 Shikoku Endometriosis Drugs Landscape Analysis by Major Types
-
12.2 Shikoku Endometriosis Drugs Landscape Analysis by Major End-Users
13 Kyushu Endometriosis Drugs Landscape Analysis
-
13.1 Kyushu Endometriosis Drugs Landscape Analysis by Major Types
-
13.2 Kyushu Endometriosis Drugs Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Pfizer
14.1.1 Pfizer Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Repros Therapeutics
14.2.1 Repros Therapeutics Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Takeda Pharmaceutical Company Limited
14.3.1 Takeda Pharmaceutical Company Limited Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 ObsEva
14.4.1 ObsEva Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Kissei Pharmaceutical
14.5.1 Kissei Pharmaceutical Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Roivant Sciences GmbH
14.6.1 Roivant Sciences GmbH Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Neurocrine Biosciences
14.7.1 Neurocrine Biosciences Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Astellas Pharma
14.8.1 Astellas Pharma Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Debiopharm Group
14.9.1 Debiopharm Group Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 AstraZeneca
14.10.1 AstraZeneca Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 ValiRx
14.11.1 ValiRx Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 AbbVie
14.12.1 AbbVie Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
14.13 Evotec AG
14.13.1 Evotec AG Company Profile and Recent Development
14.13.2 Market Performance
14.13.3 Product and Service Introduction
The List of Tables and Figures (Totals 145 Figures and 154 Tables)
Figure Japan Endometriosis Drugs Market Size and Growth Rate of Hormonal Therapy from 2014 to 2026
Figure Japan Endometriosis Drugs Market Size and Growth Rate of Add-back Medication from 2014 to 2026
Figure Japan Endometriosis Drugs Market Size and Growth Rate of Progestogens from 2014 to 2026
Figure Japan Endometriosis Drugs Market Size and Growth Rate of Chinese Herbs from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Endometriosis Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Endometriosis Drugs Market Size and Growth Rate of Clinics from 2014 to 2026
Figure Japan Endometriosis Drugs Market Size and Growth Rate of Research Institutes from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Endometriosis Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Endometriosis Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Endometriosis Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Endometriosis Drugs by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Hormonal Therapy
Figure Market Size and Growth Rate of Add-back Medication
Figure Market Size and Growth Rate of Progestogens
Figure Market Size and Growth Rate of Chinese Herbs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Endometriosis Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Endometriosis Drugs by Different End-Users from 2014 to 2026
Figure Japan Endometriosis Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Endometriosis Drugs Market Size and Growth Rate of Clinics from 2014 to 2026
Figure Japan Endometriosis Drugs Market Size and Growth Rate of Research Institutes from 2014 to 2026
-
Table Japan Endometriosis Drugs Production by Regions
-
Table Japan Endometriosis Drugs Production Share by Regions
-
Figure Japan Endometriosis Drugs Production Share by Regions in 2014
-
Figure Japan Endometriosis Drugs Production Share by Regions in 2018
-
Figure Japan Endometriosis Drugs Production Share by Regions in 2026
-
Table Japan Endometriosis Drugs Consumption by Regions
-
Table Japan Endometriosis Drugs Consumption Share by Regions
-
Figure Japan Endometriosis Drugs Consumption Share by Regions in 2014
-
Figure Japan Endometriosis Drugs Consumption Share by Regions in 2018
-
Figure Japan Endometriosis Drugs Consumption Share by Regions in 2026
-
Table Hokkaido Endometriosis Drugs Consumption by Types from 2014 to 2026
-
Table Hokkaido Endometriosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Endometriosis Drugs Consumption Share by Types in 2014
-
Figure Hokkaido Endometriosis Drugs Consumption Share by Types in 2018
-
Figure Hokkaido Endometriosis Drugs Consumption Share by Types in 2026
-
Table Hokkaido Endometriosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Endometriosis Drugs Consumption Share by End-Users in 2014
-
Figure Hokkaido Endometriosis Drugs Consumption Share by End-Users in 2018
-
Figure Hokkaido Endometriosis Drugs Consumption Share by End-Users in 2026
-
Table Tohoku Endometriosis Drugs Consumption by Types from 2014 to 2026
-
Table Tohoku Endometriosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Endometriosis Drugs Consumption Share by Types in 2014
-
Figure Tohoku Endometriosis Drugs Consumption Share by Types in 2018
-
Figure Tohoku Endometriosis Drugs Consumption Share by Types in 2026
-
Table Tohoku Endometriosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Tohoku Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Endometriosis Drugs Consumption Share by End-Users in 2014
-
Figure Tohoku Endometriosis Drugs Consumption Share by End-Users in 2018
-
Figure Tohoku Endometriosis Drugs Consumption Share by End-Users in 2026
-
Table Kanto Endometriosis Drugs Consumption by Types from 2014 to 2026
-
Table Kanto Endometriosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kanto Endometriosis Drugs Consumption Share by Types in 2014
-
Figure Kanto Endometriosis Drugs Consumption Share by Types in 2018
-
Figure Kanto Endometriosis Drugs Consumption Share by Types in 2026
-
Table Kanto Endometriosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Kanto Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Endometriosis Drugs Consumption Share by End-Users in 2014
-
Figure Kanto Endometriosis Drugs Consumption Share by End-Users in 2018
-
Figure Kanto Endometriosis Drugs Consumption Share by End-Users in 2026
-
Table Chubu Endometriosis Drugs Consumption by Types from 2014 to 2026
-
Table Chubu Endometriosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chubu Endometriosis Drugs Consumption Share by Types in 2014
-
Figure Chubu Endometriosis Drugs Consumption Share by Types in 2018
-
Figure Chubu Endometriosis Drugs Consumption Share by Types in 2026
-
Table Chubu Endometriosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Chubu Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Endometriosis Drugs Consumption Share by End-Users in 2014
-
Figure Chubu Endometriosis Drugs Consumption Share by End-Users in 2018
-
Figure Chubu Endometriosis Drugs Consumption Share by End-Users in 2026
-
Table Kinki Endometriosis Drugs Consumption by Types from 2014 to 2026
-
Table Kinki Endometriosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kinki Endometriosis Drugs Consumption Share by Types in 2014
-
Figure Kinki Endometriosis Drugs Consumption Share by Types in 2018
-
Figure Kinki Endometriosis Drugs Consumption Share by Types in 2026
-
Table Kinki Endometriosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Kinki Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Endometriosis Drugs Consumption Share by End-Users in 2014
-
Figure Kinki Endometriosis Drugs Consumption Share by End-Users in 2018
-
Figure Kinki Endometriosis Drugs Consumption Share by End-Users in 2026
-
Table Chugoku Endometriosis Drugs Consumption by Types from 2014 to 2026
-
Table Chugoku Endometriosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Endometriosis Drugs Consumption Share by Types in 2014
-
Figure Chugoku Endometriosis Drugs Consumption Share by Types in 2018
-
Figure Chugoku Endometriosis Drugs Consumption Share by Types in 2026
-
Table Chugoku Endometriosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Chugoku Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Endometriosis Drugs Consumption Share by End-Users in 2014
-
Figure Chugoku Endometriosis Drugs Consumption Share by End-Users in 2018
-
Figure Chugoku Endometriosis Drugs Consumption Share by End-Users in 2026
-
Table Shikoku Endometriosis Drugs Consumption by Types from 2014 to 2026
-
Table Shikoku Endometriosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Endometriosis Drugs Consumption Share by Types in 2014
-
Figure Shikoku Endometriosis Drugs Consumption Share by Types in 2018
-
Figure Shikoku Endometriosis Drugs Consumption Share by Types in 2026
-
Table Shikoku Endometriosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Shikoku Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Endometriosis Drugs Consumption Share by End-Users in 2014
-
Figure Shikoku Endometriosis Drugs Consumption Share by End-Users in 2018
-
Figure Shikoku Endometriosis Drugs Consumption Share by End-Users in 2026
-
Table Kyushu Endometriosis Drugs Consumption by Types from 2014 to 2026
-
Table Kyushu Endometriosis Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Endometriosis Drugs Consumption Share by Types in 2014
-
Figure Kyushu Endometriosis Drugs Consumption Share by Types in 2018
-
Figure Kyushu Endometriosis Drugs Consumption Share by Types in 2026
-
Table Kyushu Endometriosis Drugs Consumption by End-Users from 2014 to 2026
-
Table Kyushu Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Endometriosis Drugs Consumption Share by End-Users in 2014
-
Figure Kyushu Endometriosis Drugs Consumption Share by End-Users in 2018
-
Figure Kyushu Endometriosis Drugs Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Repros Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Repros Therapeutics
Figure Sales and Growth Rate Analysis of Repros Therapeutics
Figure Revenue and Market Share Analysis of Repros Therapeutics
Table Product and Service Introduction of Repros Therapeutics
Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited
Table Product and Service Introduction of Takeda Pharmaceutical Company Limited
Table Company Profile and Development Status of ObsEva
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ObsEva
Figure Sales and Growth Rate Analysis of ObsEva
Figure Revenue and Market Share Analysis of ObsEva
Table Product and Service Introduction of ObsEva
Table Company Profile and Development Status of Kissei Pharmaceutical
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kissei Pharmaceutical
Figure Sales and Growth Rate Analysis of Kissei Pharmaceutical
Figure Revenue and Market Share Analysis of Kissei Pharmaceutical
Table Product and Service Introduction of Kissei Pharmaceutical
Table Company Profile and Development Status of Roivant Sciences GmbH
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roivant Sciences GmbH
Figure Sales and Growth Rate Analysis of Roivant Sciences GmbH
Figure Revenue and Market Share Analysis of Roivant Sciences GmbH
Table Product and Service Introduction of Roivant Sciences GmbH
Table Company Profile and Development Status of Neurocrine Biosciences
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurocrine Biosciences
Figure Sales and Growth Rate Analysis of Neurocrine Biosciences
Figure Revenue and Market Share Analysis of Neurocrine Biosciences
Table Product and Service Introduction of Neurocrine Biosciences
Table Company Profile and Development Status of Astellas Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
Figure Sales and Growth Rate Analysis of Astellas Pharma
Figure Revenue and Market Share Analysis of Astellas Pharma
Table Product and Service Introduction of Astellas Pharma
Table Company Profile and Development Status of Debiopharm Group
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Debiopharm Group
Figure Sales and Growth Rate Analysis of Debiopharm Group
Figure Revenue and Market Share Analysis of Debiopharm Group
Table Product and Service Introduction of Debiopharm Group
Table Company Profile and Development Status of AstraZeneca
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
Figure Sales and Growth Rate Analysis of AstraZeneca
Figure Revenue and Market Share Analysis of AstraZeneca
Table Product and Service Introduction of AstraZeneca
Table Company Profile and Development Status of ValiRx
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ValiRx
Figure Sales and Growth Rate Analysis of ValiRx
Figure Revenue and Market Share Analysis of ValiRx
Table Product and Service Introduction of ValiRx
Table Company Profile and Development Status of AbbVie
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
Figure Sales and Growth Rate Analysis of AbbVie
Figure Revenue and Market Share Analysis of AbbVie
Table Product and Service Introduction of AbbVie
Table Company Profile and Development Status of Evotec AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Evotec AG
Figure Sales and Growth Rate Analysis of Evotec AG
Figure Revenue and Market Share Analysis of Evotec AG
Table Product and Service Introduction of Evotec AG
-
